Hepatitis B virus, also known as HBV or Orthohepadnavirus, is a type of virus that belongs to the Hepadnaviridae family of viruses. Hepatitis B is brought on by the virus HBV. The ground squirrel hepatitis virus, the woodchuck hepatitis virus, and the woolly monkey hepatitis B virus are the other three species that make up the Orthohepadnavirus, of which the hepatitis B virus is the type species. The Hepadnaviridae family includes the genus as a member. Based on antigenic epitopes found on its envelope proteins, HBV is classified into four major serotypes (adr, adw, ayr, ayw), and eight genotypes (A-H) based on the genome's overall nucleotide sequence variation.The genotypes are used to track the evolution and spread of the virus because they have a distinct geographic distribution. The severity of the disease, the progression and propensity for complications, the response to treatment, and perhaps vaccination, are all impacted by genotype differences.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V54198 | Schisanwilsonin C (Arisanschinin K) | 1181216-83-0 | Schisanwilsonin C (Arisanschinin K) has anti-HBV (hepatitis B virus) activity. |
|
V35025 | Sophoranol (Sophoranol) | 3411-37-8 | Sophoranol is an alkaloid extracted from S. flavescens and has antiviral effect. |
|
V54207 | Tiviciclovir (AM188) | 103024-93-7 | Tiviciclovir (AM188) is an antiviral guanosine analog and a hepatitis B virus inhibitor. |
|
V84061 | Tiviciclovir hydrochloride (AM188 hydrochloride) | ||
|
V54184 | TLR8 agonist 4 | 2761697-69-0 | TLR8 agonist 4 displays potent inhibitory effects on both wild-type and drug-resistant (lamivudine and entecavir) HBV (hepatitis B virus) strains. |
|
V53363 | trans-ccc_R08 | 2413192-49-9 | trans-ccc_R08 (compound 1-B) is a potent cccDNA (covalently closed cyclic DMA) inhibitor. |
|
V54194 | Xalnesiran | 2538784-48-2 | Xalnesiran is an siRNA used to treat chronic HBV (hepatitis B virus). |
|
|
V54199 | Xalnesiran sodium | 2538784-49-3 | Xalnesiran (sodium) is an siRNA used to treat chronic HBV (hepatitis B virus). |
|
V54192 | Yhhu6669 | 2569526-80-1 | Yhhu6669 is an anti-HBV (hepatitis B virus) drug. |
|
V105333 | ZINC20451377 | 2306303-35-3 | ZINC20451377 is a small molecule targeting hepatitis B (HBV) surface antigen (HBsAg) that can effectively inhibit wild-type HBV and tenofovir-resistant HBV. |
|
V14774 | Vidarabine phosphate | 29984-33-6 | Vidarabine phosphate is an adenosine monophosphate analogue in which ribose is replaced by an arabinose moiety. |
|
V41537 | Bulevirtide (Myrcludex B; MyrB) | 2012558-47-1 | Bulevirtide (Myrcludex B; MyrB; Hepcludex) is a first-in-class entry inhibitor approved as an antiviral medication for the treatment of chronic hepatitis D. |
|
V30082 | 4,5-Dicaffeoylquinic acid | 57378-72-0 | 4,5-Dicaffeoylquinic acid is a novel and potent hepatoprotective and anti-HBV effects. |
|
V29343 | Isoscopoletin | 776-86-3 | Isoscopoletin is a novel and potent bioactive compound. |
|
V3511 | Entecavir (SQ 34676) | 142217-69-4 | Entecavir (Baraclude;SQ34676 and BMS200475), anti-hepatitis B virus (HBV) agent,is a novel deoxyguanine nucleoside analogue and areverse transcriptase inhibitor. |
|
V16597 | Torcitabine | 40093-94-5 | Torcitabine (2'-Deoxy-L-cytidine) is an antiviral active molecule. |
|
V5190 | Morphothiadin (GLS4) | 1092970-12-1 | Morphothiadin (formerly GLS-4; GLS4) is a novel, potent and selective inhibitor of HBV replication, effective against both wild-type and adefovir-resistant HBV with an IC50of 12 nM. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
